$PBIO is expecting this years revenue to double fr

$PBIO is expecting this years revenue to double from $2.5 million to $5 million as a result of the high demand expected for the company's BaroShear K45 technology. Technology companies with 100% growth rates can easily trade at upwards of 10 times annual sales which could realistically lead to a $50 million valuation for the company's stock. With less than 2 million shares outstanding the stock may move significantly higher from current levels in the near term as the current market capitalization is a miniscule $5.9 million offering a substantial upside to the company's shares. Trading at only 1.2 times this years forecasted sales PBIO is a very cheap stock compared with its CBD industry peers. The company previously traded on the NASDAQ for upwards of $18.00. The CBD market is hot and valuations are soaring. PBIO is a great way to add the extraordinary growth of the CBD sector to your portfolio.
https://privateequitymarkets.us/newsletter/pb...essing-cbd